BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22123697)

  • 1. Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.
    Liu Z; Nachamkin I; Edelstein PH; Lautenbach E; Metlay JP
    Antimicrob Agents Chemother; 2012 Feb; 56(2):743-50. PubMed ID: 22123697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
    Wierzbowski AK; Karlowsky JA; Adam HJ; Nichol KA; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2014 Jan; 69(1):59-66. PubMed ID: 23970485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypes and serotype distribution of macrolide resistant invasive and non-invasive Streptococcus pneumoniae isolates from Lebanon.
    Taha N; Araj GF; Wakim RH; Kanj SS; Kanafani ZA; Sabra A; Khairallah MT; Nassar FJ; Shehab M; Baroud M; Dbaibo G; Matar GM
    Ann Clin Microbiol Antimicrob; 2012 Jan; 11():2. PubMed ID: 22248318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular resistance mechanisms of macrolide-resistant invasive Streptococcus pneumoniae isolates from Alaska, 1986 to 2010.
    Rudolph K; Bulkow L; Bruce M; Zulz T; Reasonover A; Harker-Jones M; Hurlburt D; Hennessy T
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5415-22. PubMed ID: 23959308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
    Xu X; Cai L; Xiao M; Kong F; Oftadeh S; Zhou F; Gilbert GL
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1152-9. PubMed ID: 20065057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance Mechanisms.
    Schroeder MR; Chancey ST; Thomas S; Kuo WH; Satola SW; Farley MM; Stephens DS
    Clin Infect Dis; 2017 Sep; 65(6):990-998. PubMed ID: 28903506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.
    Kasahara K; Maeda K; Mikasa K; Uno K; Takahashi K; Konishi M; Yoshimoto E; Murakawa K; Kita E; Kimura H
    J Clin Microbiol; 2005 Apr; 43(4):1640-5. PubMed ID: 15814978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
    Ikenaga M; Kosowska-Shick K; Gotoh K; Hidaka H; Koga H; Masunaga K; Nagai K; Tsumura N; Appelbaum PC; Matsuishi T
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):16-22. PubMed ID: 18068325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece.
    Grivea IN; Sourla A; Ntokou E; Chryssanthopoulou DC; Tsantouli AG; Syrogiannopoulos GA
    BMC Infect Dis; 2012 Oct; 12():255. PubMed ID: 23057516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia.
    Mayanskiy N; Alyabieva N; Ponomarenko O; Lazareva A; Katosova L; Ivanenko A; Kulichenko T; Namazova-Baranova L; Baranov A
    Int J Infect Dis; 2014 Mar; 20():58-62. PubMed ID: 24462930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.
    Kawaguchiya M; Urushibara N; Ghosh S; Kuwahara O; Morimoto S; Ito M; Kudo K; Kobayashi N
    Microb Drug Resist; 2014 Oct; 20(5):456-65. PubMed ID: 24766085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serotype distribution and antibiotic susceptibilities of Streptococcus pneumoniae causing acute exacerbations and pneumonia in children with chronic respiratory diseases].
    Altınkanat Gelmez G; Soysal A; Kuzdan C; Karadağ B; Hasdemir U; Bakır M; Söyletir G
    Mikrobiyol Bul; 2013 Oct; 47(4):684-92. PubMed ID: 24237437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N
    J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
    J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009.
    Fenoll A; Aguilar L; Vicioso MD; Gimenez MJ; Robledo O; Granizo JJ
    BMC Infect Dis; 2011 Sep; 11():239. PubMed ID: 21910891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.